Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Antigens, Cf (Including Cf Control), Coxsackievirus A 1-24, B 1-6

FDA product code GNG · 2 cleared devices

Class 1 Microbiology
Regulation
21 CFR 866.3145
Review panel
MI
Implant
No
Life sustaining
No
Third party review
No
GMP exempt
No
Clearance span
1985-03-05 – 1992-06-29
↑